Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size for studying intermediate endpoints within intervention trails or observational studies.

L S Freedman1, A Schatzkin

  • 1Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892.

American Journal of Epidemiology
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A historical cohort study on glycemic-control and cancer-risk among patients with diabetes.

Cancer epidemiology·2018
Same author

Seasonal variations in the clinical of presentation of Crohn's disease and ulcerative colitis.

International journal of epidemiology·2013
Same author

Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study.

European journal of clinical nutrition·2013
Same author

Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group.

Bone marrow transplantation·2012
Same author

Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study.

Cancer epidemiology·2011
Same author

Alcohol consumption and risk of renal cell cancer: the NIH-AARP diet and health study.

British journal of cancer·2011
Same journal

A decision-theoretic framework for uncertainty quantification in epidemiological modelling.

American journal of epidemiology·2026
Same journal

U.S. cardiovascular mortality before and during COVID-19: CDC WONDER vs GBD comparison.

American journal of epidemiology·2026
Same journal

Design and procedures for the greenness, cognitive performance and vascular outcomes in the northern Manhattan study (NOMAS-greenness).

American journal of epidemiology·2026
Same journal

Correction to: Home dampness and molds and occurrence of respiratory tract infections in the first 27 years of life: the Espoo Cohort Study.

American journal of epidemiology·2026
Same journal

A SIMPLE AND POWERFUL TEST OF VACCINE WANING.

American journal of epidemiology·2026
Same journal

Association Between maternal body mass index, offspring growth and pubertal timing: results from a longitudinal birth cohort study.

American journal of epidemiology·2026
See all related articles

Intermediate endpoints, like CD4 counts for AIDS, can predict health outcomes. Different research questions regarding these markers have varying sample size needs, impacting study design.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Epidemiology

Background:

  • Intermediate endpoints are biological markers preceding a health outcome.
  • Examples include serum cholesterol for heart disease and CD4 counts for AIDS.
  • These markers are crucial in intervention and observational studies.

Purpose of the Study:

  • To analyze sample size requirements for different questions about intermediate endpoints.
  • To demonstrate how these requirements vary in intervention and observational studies.
  • To provide a framework for designing studies utilizing intermediate endpoints.

Main Methods:

  • The study outlines five key questions investigated in intervention trials concerning intermediate endpoints.
  • It discusses the application of these methods in observational studies.

Related Experiment Videos

  • Sample size calculations are illustrated using data from the National Cancer Institute's Polyp Prevention Trial.

    • Main Results:

    • Each of the five research questions regarding intermediate endpoints has distinct sample size requirements.
    • Sample size needs differ significantly between intervention and observational study designs.
    • Rare main outcomes necessitate substantially larger sample sizes in observational studies.

    Conclusions:

    • Understanding varying sample size needs is critical for efficient study design involving intermediate endpoints.
    • The methods presented can guide researchers in determining appropriate sample sizes for intervention and observational studies.
    • Accurate sample size determination enhances the statistical power and validity of research on intermediate endpoints.